Biologic treatments for psoriasis in China: current status and potential tuberculosis and hepatitis B virus risks

摘要：

Introduction Psoriasis is a chronic,recurrent skin disease featured by scaly papules or plaques.Although the vast majority of patients have mild psoriasis,approxi-mately 20％-30％ of patients have moderate or severe psoriasis,which is defined as body surface area (BSA) ＞ 10,psoriasis area and severity index (PASI) ＞ 10,and dermatology life quality index (DLQI) ＞ 10.These patients have severe symptoms and worse quality of life,warranting consideration of systemic therapy”1”.Biologic treatments directly target specific steps in the pathogenesis of psoriasis,providing a revolution for treatment.

资助基金：the Key Program of the National Natural Science Foundation of China81430073;General Program of the National Science Foundation of China81371738

在线出版日期：2018-08-13（万方平台首次上网日期，不代表论文的发表时间）

页数：共8页

页码：99-106